Dr. Philbin is a social and behavioral scientist whose work integrates community-based and social determinants of health frameworks to examine how social policies and clinical practices shape inclusion and health equity for racial/ethnic and sexual and gender minority (SGM) young people. Dr. Philbin completed her MHS and PhD at the Johns Hopkins Bloomberg School of Public Health, and her Postdoctoral Fellowship in the Division of Gender, Sexuality and Health (HIV Center for Clinical and Behavioral Studies) at Columbia University. Her current research, a NIDA-funded K01, integrates national-level data and qualitative methods to examine how social policies affect health equity for minoritized youth and young adults with a focus on mental health, sexual health and substance use. Her work also examines how social policies and clinical practices can entrench racism and sexism in healthcare in ways that constrain sexual and mental healthcare access for Latinx, Black and SGM individuals, with a focus on biomedical HIV technologies. She is currently PI of an R34 that is developing a patient decision aid to help minoritized women and providers choose between oral and long-acting injectable HIV medication. She is Co-I on multiple NIH-funded projects, including a COVID RADx grant focused on preventive behaviors among BIPOC and SGM youth, an R01 exploring how state-level social policies impact mental health substance use outcomes for BIPOC and SGM youth, and two grants from the Canadian Institutes of Health focused on substance use, mental health and SGM individuals. She was recently awarded the 2021 NIH Office of Disease Prevention Early Stage Investigator Lecture Award for her work on HIV treatment and prevention.
PhD, 2013, Johns Hopkins Bloomberg School of Public Health
MHS, 2007, Johns Hopkins Bloomberg School of Public Health
BA, 2004, Wesleyan University
Member Migration and Immigration Core, Columbia Population Research Center
Member Development Core, HIV Center for Clinical and Behavioral Studies
Honors & Awards
National Institutes of Health, Office of Disease Prevention, 2021 Early Stage Investigator Lecture Award
Travel Award for Early Career Investigators. College on Problems of Drug Dependence
Fellow. Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute.
Excellence in Abstract Submission for New Investigators. HIV/AIDS Section. American Public Health Association
NIH Loan Repayment Program. National Center on Minority Health & Health Disparities. (2014-2017)
Areas of Expertise
Adolescent Health, Disparities / Inequalities in Health, Immigrant Health, Minority Health, Underserved Populations, HIV/AIDS, Lesbian / Gay / Bisexual / Transgender Health, Sexuality, Urban Health
Philbin MM*, Perez-Brumer A. (2022) Promise, Perils and Cautious Optimism: The Next Frontier in Long-Acting Modalities for the Treatment and Prevention of HIV. Current Opinions in HIV and AIDS. 7(2): 72-89
Philbin MM, Parish C, Kinnard EN, Reed SE, Kerrigan D, Alcaide M, Cohen M, Sosanya O, Sheth AN, Adimora AA, Cocohoba J, Goparaju L, Golub E, Fischl M, Metsch LR. (2020) Multisite Study of Women Living With HIV and Perceived Barriers to, and Interest in, Long Acting Injectable Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndrome (JAIDS) 84(3).
Philbin MM, Wang X, Feaster DJ, LaBossier N, Phillips G. (In press) LGB-affirming school climates and sexual health outcomes among US high school students 2015-2017: Differences by sex and sexual identity. Journal of Adolescent Health
Philbin MM, Mauro PM, Santaella-Tenorio*, Mauro CM, Kinnard EN*, Cerdá M, Martins SS. (In Press) Associations between state-level policy liberalism, cannabis use, and cannabis use disorder from 2004 to 2012: Looking beyond medical cannabis law status. International Journal of Drug Policy. NIHMSID: 1521181
Philbin MM, Flake ML, Hatzenbuehler ML, Hirsch JS. (2018) State-level immigration and immigrant-focused policies as drivers of Latino health disparities in the United States. Social Science and Medicine. http://dx.doi.org/10.1016/j.socscimed.2017.04.007. NIHMS867806
Philbin MM, Feaster DJ, Gooden L, Duan R, Das M, Jacobs P… Metsch LR. (2019) The North-South divide: substance use risk, care engagement, and viral suppression among hospitalized HIV-infected patients in 11 U.S. cities. Clinical Infectious Diseases. 68(1):146-149
Philbin MM, Parker CM*, Parker RG, Wilson PA, Garcia J, Hirsch JS. (2018) Gendered social institutions and preventive healthcare seeking for Black men who have sex with men: the promise of biomedical HIV prevention. Archives of Sexual Behavior. 47(7): 2091-2100. [PMC6309278]
Bayer R, Philbin MM, Remien R. (In Press) The End of Written Informed Consent for HIV Testing in New York State: Not with a Bang but with a Whimper. American Journal of Public Health. NIHMS866278
Philbin MM, Wilson PA, Parker RG, Parker CM*, Garcia J, Hirsch JS. (2016) The Promise of pre-exposure prophylaxis (PrEP) for Black MSM in New York City: An ecological approach to attitudes, beliefs, and barriers. AIDS Patient Care and STDs. 30(6): 282-290 [PMC4913505]
Philbin MM, Tanner AE, DuVal A, Xu, JH, Ellen JM, Bethel J, Kapogiannis B, Fortenberry JD. (2016) HIV testing, care referral and linkage to care intervals affect time to engagement in care for newly diagnosed HIV-infected adolescents in fifteen adolescent medicine clinics in the United States. JAIDS. 72(2): 222-229